Cargando…
Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
Oncolytic virotherapy has been an attractive drug platform for targeted therapy of cancer over the past few years. Viral vectors can be used to target and lyse cancer cells, but achieving good efficacy and specificity with this treatment approach is a major challenge. Here, we assessed the ability o...
Autores principales: | He, Dongyun, Sun, Lili, Li, Chang, Hu, Ningning, Sheng, Yuan, Chen, Zhifei, Li, Xiao, Chi, Baorong, Jin, Ningyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939485/ https://www.ncbi.nlm.nih.gov/pubmed/24553109 http://dx.doi.org/10.3390/v6020856 |
Ejemplares similares
-
Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivo
por: YANG, GUOHUA, et al.
Publicado: (2015) -
Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo
por: Xiao, Li, et al.
Publicado: (2010) -
Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent
por: Baradaran, Ali, et al.
Publicado: (2016) -
Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus
por: Jin, Zhongyuan, et al.
Publicado: (2021) -
Hemagglutinin-neuraminidase gene of genotype VII Newcastle disease virus strains isolated in Japan
por: MASE, Masaji
Publicado: (2021)